Cytotoxicity assays are developed to analyze the ability of the lead compound/s to destroy healthy cells. During the preclinical research phases of drug discovery and development, cytotoxicity assays are not only important to assess the safety profile and identify off-target effects but can help save money before moving to expensive in-vivo studies. Our cytotoxic assays are designed to quantify the relative number of dead cells in a population. Our team of experienced scientists will help to choose the appropriate cytotoxic assay/s based on the characteristics of the drug and careful consideration of its cellular and molecular functions.